|
1 |
01 07 2025 |
Indian pharma firms invited to supply medicines to Venezuela's Ministry of Education |
Pharmabiz |
India |
|
2 |
01 07 2025 |
DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity |
Pharmabiz |
India |
|
3 |
01 07 2025 |
Marksans Pharma rises after subsidiary gets EIR for New York-based facility from US FDA |
Business Standard |
India |
|
4 |
01 07 2025 |
Telangana pharma factory blast: Death toll rises to 35, DNA identification under way at Patancheru hospital |
The Hindu |
India |
|
5 |
30 06 2025 |
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain |
Pharmabiz |
India |
|
6 |
30 06 2025 |
DCGI responds on clarifications sought by Pharmexcil on export NOC guidance document |
Pharmabiz |
India |
|
7 |
30 06 2025 |
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules |
Pharmabiz |
India |
|
8 |
30 06 2025 |
Indian pharma eyes US gains as $63.7 bn patent cliff nears: Analysts |
Business Standard |
India |
|
9 |
30 06 2025 |
India’s Torrent Pharma to acquire controlling stake in JB Chem and Pharma |
Business Recorder |
India |
|
10 |
30 06 2025 |
Telangana DCA's arrests of wholesalers for spurious drugs trigger nationwide call for stronger enforcement |
Pharmabiz |
India |
|
11 |
30 06 2025 |
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar |
Pharmabiz |
India |
|
12 |
30 06 2025 |
Intas gets SEC NOD to import , Market Anti- Cancer drug Serplulimab , Phase IV trail Mandated |
Medical Dialogues |
India |
|
13 |
28 06 2025 |
15 Drug including Pomol-650, Glimiz-2 banned in Karanataka, check full list |
Medical Dialogues |
India |
|
14 |
28 06 2025 |
CDSCO asks Serum Institute to revise protocol for Trivalent Flu- Covid vaccine Trail |
Medical Dialogues |
India |
|
15 |
28 06 2025 |
Biocon Biologics Yesafili gets Health Canada nod for Eye Diseases |
Medical Dialogues |
India |
|
16 |
28 06 2025 |
WHO issues alert on the use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy |
Pharmabiz |
India |
|
17 |
28 06 2025 |
Indian pharma speeds up access to global therapies while targeting treatment gaps |
Pharmabiz |
India |
|
18 |
28 06 2025 |
Experts discuss solutions in enhancing API manufacturing quality at USP Convention 2025 |
Pharmabiz |
India |
|
19 |
28 06 2025 |
Centre makes application for WHO GMP & COPP mandatory through ONLDS portal from July 15 |
Pharmabiz |
India |
|
20 |
28 06 2025 |
A.P. govt. urged to set up pharma innovation centre in Srikakulam district |
The Hindu |
India |
